Other NF2 Deficient Solid Tumors and Solid Tumors with YAP1/TAZ Fusion Genes
1 clinical trials · Condition
◉ Watch Other NF2 Deficient Solid Tumors and Solid Tumors with YAP1/TAZ Fusion Genes
| Record | Firm | Date |
|---|---|---|
| Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors (NCT05228015) | Ikena Oncology | 2022-01-07 |
Track Other NF2 Deficient Solid Tumors and Solid Tumors with YAP1/TAZ Fusion Genes automatically
Every clearance here is in the API, with alerts when new ones post.